Crestor, after setback in Lipitor trial, may take sales hit

Lauren Folino

September 02 2011

AstraZeneca's top-selling product, Crestor (rosuvastatin), is looking shaky after results from SATURN, a head-to-head study pitting the statin against Pfizer's ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.